Nothing Special   »   [go: up one dir, main page]

DK3157522T3 - Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste - Google Patents

Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste Download PDF

Info

Publication number
DK3157522T3
DK3157522T3 DK15728025T DK15728025T DK3157522T3 DK 3157522 T3 DK3157522 T3 DK 3157522T3 DK 15728025 T DK15728025 T DK 15728025T DK 15728025 T DK15728025 T DK 15728025T DK 3157522 T3 DK3157522 T3 DK 3157522T3
Authority
DK
Denmark
Prior art keywords
combinations
treatment
horse
diseases
muscarin
Prior art date
Application number
DK15728025T
Other languages
English (en)
Inventor
Michael Aven
Janine Lamar
Balazs Albrecht
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Application granted granted Critical
Publication of DK3157522T3 publication Critical patent/DK3157522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2250/00—Specially adapted for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15728025T 2014-06-18 2015-06-15 Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste DK3157522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14172925 2014-06-18
PCT/EP2015/063265 WO2015193213A1 (en) 2014-06-18 2015-06-15 Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
DK3157522T3 true DK3157522T3 (da) 2019-12-09

Family

ID=50972546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15728025T DK3157522T3 (da) 2014-06-18 2015-06-15 Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste

Country Status (17)

Country Link
US (3) US9474747B2 (da)
EP (2) EP3157522B1 (da)
KR (1) KR102618119B1 (da)
AU (2) AU2015276310B2 (da)
CA (1) CA2952701C (da)
CY (1) CY1122335T1 (da)
DK (1) DK3157522T3 (da)
ES (1) ES2759247T3 (da)
HR (1) HRP20192010T1 (da)
HU (1) HUE051527T2 (da)
LT (1) LT3157522T (da)
MX (2) MX370430B (da)
PL (1) PL3157522T3 (da)
PT (1) PT3157522T (da)
RS (1) RS59613B1 (da)
SI (1) SI3157522T1 (da)
WO (1) WO2015193213A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2934479B1 (en) 2012-12-21 2018-09-19 Boehringer Ingelheim Vetmedica GmbH Ciclesonide for the treatment of airway disease in horses
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
EP3157522B1 (en) 2014-06-18 2019-09-04 Boehringer Ingelheim Vetmedica GmbH Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
CN111840256A (zh) * 2019-04-29 2020-10-30 上海谷森医药有限公司 一种雾化吸入剂及其制备方法
CN112752572B (zh) 2019-05-23 2022-02-22 广州谷森制药有限公司 含有三苯乙酸维兰特罗和芜地溴铵的可吸入溶液组合物
US20220031712A1 (en) * 2020-06-23 2022-02-03 Cai Gu Huang Preparation of a pharmaceutical composition of olodaterol and budesonide
CN115989032A (zh) 2020-07-31 2023-04-18 化学研究有限公司 用于吸入施用的组合疗法
US11844793B2 (en) 2020-09-29 2023-12-19 Aerorx Therapeutics Llc Liquid formulations of indacaterol

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) * 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) * 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
AU2003272450A1 (en) * 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
EP1635844A1 (en) 2003-05-22 2006-03-22 ALTANA Pharma AG Salmeterol and ciclesonide combination
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (en) 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1763344A1 (en) 2004-06-29 2007-03-21 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
US20070028923A1 (en) 2005-08-08 2007-02-08 Patrick Souris Tip-laryngeal airway
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
WO2010049280A2 (de) 2008-10-30 2010-05-06 Siemens Aktiengesellschaft Verfahren zur einstellung einer auslaufdicke eines eine mehrgerüstige walzstrasse durchlaufenden walzguts, steuer- und/oder regeleinrichtung und walzanlage
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN102458541A (zh) * 2009-06-25 2012-05-16 贝林格尔.英格海姆维特梅迪卡有限公司 吸入器
EA201590030A1 (ru) * 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US20150202148A1 (en) * 2012-07-05 2015-07-23 Arven llac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
US9539408B2 (en) * 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
LT3473255T (lt) * 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
EP2934479B1 (en) 2012-12-21 2018-09-19 Boehringer Ingelheim Vetmedica GmbH Ciclesonide for the treatment of airway disease in horses
CA3129707C (en) * 2013-08-20 2023-04-25 Boehringer Ingelheim Vetmedica Gmbh Inhaler
PT3035885T (pt) * 2013-08-20 2020-04-01 Boehringer Ingelheim Vetmedica Gmbh Inalador
EP3157522B1 (en) 2014-06-18 2019-09-04 Boehringer Ingelheim Vetmedica GmbH Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

Also Published As

Publication number Publication date
KR20170016986A (ko) 2017-02-14
EP3157522B1 (en) 2019-09-04
US10682345B2 (en) 2020-06-16
WO2015193213A1 (en) 2015-12-23
US20170007593A1 (en) 2017-01-12
US10342789B2 (en) 2019-07-09
ES2759247T3 (es) 2020-05-08
US20190262329A1 (en) 2019-08-29
US9474747B2 (en) 2016-10-25
CA2952701C (en) 2023-09-19
AU2015276310A1 (en) 2016-12-08
SI3157522T1 (sl) 2020-01-31
LT3157522T (lt) 2019-11-25
EP3603640A1 (en) 2020-02-05
AU2020202402B2 (en) 2021-05-27
EP3157522A1 (en) 2017-04-26
KR102618119B1 (ko) 2023-12-27
HRP20192010T1 (hr) 2020-02-07
HUE051527T2 (hu) 2021-03-01
CY1122335T1 (el) 2021-01-27
MX2019014935A (es) 2020-02-13
PL3157522T3 (pl) 2020-03-31
CA2952701A1 (en) 2015-12-23
US20150366855A1 (en) 2015-12-24
RS59613B1 (sr) 2020-01-31
PT3157522T (pt) 2019-12-13
MX2016016720A (es) 2017-04-13
AU2020202402A1 (en) 2020-04-30
AU2015276310B2 (en) 2020-01-16
MX370430B (es) 2019-12-13

Similar Documents

Publication Publication Date Title
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3212255T3 (da) Selvorienterende sprøjte og sprøjtegrænseflade
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3183010T3 (da) Anordning og tilhørende fremgangsmåde til behandling af medicinsk affald
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3157522T3 (da) Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3103715T3 (da) Styreindretning og styringsfremgangsmåde dertil
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande